Please enable JavaScript.  This webapp requires JavaScript to work at its best.

Case Example: Managing AEs with Dose Adjustment


Prof. Jeff Evans presents a case study of a typical patient that offers guidance on how to manage side effects in patients with advanced hepatocellular carcinoma (HCC) who are taking LENVIMA.

Prof. Jeff Evans describes how dose reduction can be used to manage side effects such as hypertension, proteinuria and diarrhoea.

Please note that the AE management & monitoring guide can also be downloaded from Eisaipro. Click ‘Back to Resources’.

Supporting documentation:

LENVIMA® 4mg hard capsules  Summary of Product Characteristics


UK-LENA-23-00099   Date of preparation March 2023